Type I collagen glomerulopathy: Postnatal collagen deposition follows glomerular maturation

Kidney International

Volumn 71, Issue 10, 2007, Pages 985-993

  Brodeur, A C ^a   Wirth, D A ^a   Franklin, C L ^b   Reneker, L W ^a   Miner, J H ^c   Phillips, C L ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; Glomerular development; Glomerulosclerosis; Podocyte; Type I collagen

Indexed keywords

COLLAGEN 1A2; COLLAGEN TYPE 1; MESSENGER RNA; PROCOLLAGEN ALPHA 2; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; GENE DOSAGE; GENOTYPE; GLOMERULOPATHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MESANGIUM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TYPE I COLLAGEN GLOMERULONEPHROPATHY; WILD TYPE;

ALBUMINURIA; ANIMALS; ANIMALS, NEWBORN; COLLAGEN; COLLAGEN TYPE I; HETEROZYGOTE; HOMEOSTASIS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; RNA, MESSENGER;

EID: 34248591801     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002173     Document Type: Article

References (50)

1. Phillips CL, Pfeiffer BJ, Luger AM et al. Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int 2002; 62: 383-391.
2. Jimenez SA, Bashey RI, Benditt M et al. Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. Biochem Biophys Res Commun 1977; 78: 1354-1361.
3. Yoshioka K, Tohda M, Takemura T et al. Distribution of type I collagen in human kidney diseases in comparison with type III collagen. J Pathol 1990; 162: 141-148.
4. Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994; 23: 193-198.
5. Glick AD, Jacobson HR, Haralson MA. Mesangial deposition of type I collagen in human glomerulosclerosis. Hum Pathol 1992; 23: 1373-1379.
6. McLennan SV, Death AK, Fisher EJ et al. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol (Noisy-le-grand) 1999; 45: 123-135.
7. Haralson MA, Jacobson HR, Hoover RL. Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 1987; 57: 513-523.
8. Johnson RJ, Floege J, Yoshimura A et al. The activated mesangial cell: a glomerular 'myofibroblast'? J Am Soc Nephrol 1992; 2: S190-197.
9. Cotran RS, Kumar V, Collins T et al. Robbins Pathologic Basis of Disease. 6th edn. Philadelphia: W.B. Saunders, 1999.
10. Cohen IK, Diegelmann RF, Lindblad WJ. Wound Healing : Biochemical & Clinical Aspects. Philadelphia: WB Saunders Co., 1992.
11. Scriver CR. The Metabolic Basis of Inherited Disease. 6th edn, New York: McGraw-Hill, 1989.
12. Rupard JH, Dimari SJ, Damjanov I et al. Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. Am J Pathol 1988; 133: 316-326.
13. Uitto J. Collagen polymorphism: isolation and partial characterization of alpha 1(I)-trimer molecules in normal human skin. Arch Biochem Biophys 1979; 192: 371-379.
14. Ghersi G, La Fiura AM, Minafra S. Direct adhesion to type I and homotrimer collagens by breast carcinoma and embryonic epithelial cells in culture: a comparative study. Eur J Cell Biol 1989; 50: 279-284.
15. Moro L, Smith BD. Identification of collagen alpha1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. Arch Biochem Biophys 1977; 182: 33-41.
16. Deak SB, Nicholls A, Pope FM et al. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem 1983; 258: 15192-15197.
17. McBride DJ, Choe V, Shapiro JR et al. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol 1997; 270: 275-284.
18. Chipman SD, Sweet HO, McBride DJ et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 1993; 90: 1701-1705.
19. Andrews KL, Betsuyaku T, Rogers S et al. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am J Pathol 2000; 157: 303-311.
20. Spitzer A, Brandis M. Functional and morphologic maturation of the superficial nephrons. Relationship to total kidney function. J Clin Invest 1974; 53: 279-287.
21. Kleinman LI, Reuter JH. Maturation of glomerular blood flow distribution in the new-born dog. J Physiol 1973; 228: 91-103.
22. Bard J. Embryos: Color Atlas of Development. London Wolfe, 1994.
23. Potter EL. Development of the human glomerulus. Arch Pathol 1965; 80: 241-255.
24. Aperia A, Herin P. Development of glomerular perfusion rate and nephron filtration rate in rats 17-60 days old. Am J Physiol 1975; 228: 1319-1325.
25. Mozes MM, Bottinger EP, Jacot TA et al. Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol 1999; 10: 271-280.
26. Francki A, Bradshaw AD, Bassuk JA et al. SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem 1999; 274: 32145-32152.
27. Chatziantoniou C, Boffa JJ, Ardaillou R et al. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. J Clin Invest 1998; 101: 2780-2789.
28. Uchio K, Manabe N, Tamura K et al. Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain). Nephron 2000; 86: 145-151.
29. Uchio-Yamada K, Manabe N, Goto Y et al. Decreased expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in the kidneys of hereditary nephrotic (ICGN) mice. J Vet Med Sci 2005; 67: 35-41.
30. Tomita M, Koike H, Han GD et al. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion. Clin Exp Nephrol 2004; 8: 17-26.
31. Uchio K, Manabe N, Yamaguchi-Yamada M et al. Changes in the localization of type I, III and IV collagen mRNAs in the kidneys of hereditary nephritic (ICGN) mice with renal fibrosis. J Vet Med Sci 2004; 66: 123-128.
32. Zlotogora J. Dominance and homozygosity. Am J Med Genet 1997; 68: 412-416.
33. Rousseau F, Bonaventure J, Legeai-Mallet L et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371: 252-254.
34. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307.
35. Laurens W, Battaglia C, Foglieni C et al. Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int 1995; 47: 1078-1086.
36. Sanderson N, Factor V, Nagy P et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92: 2572-2576.
37. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003.
38. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456.
39. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000; 11: 574-581.
40. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12: 1315-1325.
41. Cortes P, Riser BL, Yee J et al. Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. Nephrol Dial Transplant 1999; 14: 1351-1354.
42. Pfeiffer BJ, Franklin CL, Hsieh FH et al. Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. Matrix Biol 2005; 24: 451-458.
43. 3 collagen mouse model. J Vasc Surg 2001; 33: 1263-1270.
44. Krepinsky JC, Li Y, Chang Y et al. Akt mediates mechanical strain-induced collagen production by mesangial cells. J Am Soc Nephrol 2005; 16: 1661-1672.
45. Phillips CL, Bradley DA, Schlotzhauer CL et al. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 2000; 27: 219-226.
46. Noakes PG, Miner JH, Gautam M et al. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet 1995; 10: 400-406.
47. Kikkawa Y, Virtanen I, Miner JH. Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane. J Cell Biol 2003; 161: 187-196.
48. O'Garra A, Chang R, Go N et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-717.
49. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998; 24: 954-958, 960, 962.
50. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169-193.